Literature DB >> 15767434

Wide range of quasispecies diversity during primary hepatitis C virus infection.

Belinda L Herring1, Rose Tsui, Lorraine Peddada, Michael Busch, Eric L Delwart.   

Abstract

Hepatitis C virus (HCV) infections may be initiated by multiple infectious particles, resulting in a genetically heterogeneous viral population, or by a single particle, leading to a clonal population in the initial stage of infection. To determine which of these scenarios is most common, we evaluated the genetic diversity of HCV quasispecies in 12 seronegative subjects with primary infection following community exposures, six acutely infected recipients of HCV-seropositive blood transfusions and six seropositive individuals with infections of undetermined durations. RNA isolated from plasma and a region of the HCV envelope gene including the first hypervariable region (HVR-1) was reverse transcription-PCR amplified and subcloned, and multiple plasmid clones were sequenced. Phylogenetic analysis indicated that all HCV variants clustered by individuals. Genetic distances among HCV variants within recently infected subjects ranged from 1 to 7.8%. On the basis of the estimated mutation rate of HCV in vivo and the Taq polymerase error rate, primary infection viral quasispecies were classified as genetically heterogeneous when the maximum sequence divergence between genetic variants in the same person was >3%. Heterogeneous quasispecies were detected in 4 of 12 preseroconversion subjects, 1 of 6 transfusion recipients, and 4 of 6 seropositive subjects. The high level of viral quasispecies genetic diversity found in at least a third of recently infected individuals is consistent with the transmission of multiple infectious particles. Community-acquired HCV infection, predominantly the result of needle sharing by injection drug users, therefore appears to be frequently initiated by the successful transmission of multiple viral variants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767434      PMCID: PMC1061543          DOI: 10.1128/JVI.79.7.4340-4346.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.

Authors:  Hideyuki Nomura; Suketo Sou; Hironori Tanimoto; Takashi Nagahama; Yoichi Kimura; Jun Hayashi; Hiromi Ishibashi; Seizaburo Kashiwagi
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

2.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

Review 3.  Virus 'quasispecies': making a mountain out of a molehill?

Authors:  D B Smith; J McAllister; C Casino; P Simmonds
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

4.  Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis.

Authors:  E L Delwart; C J Gordon
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

5.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

Authors:  K M Chang; B Rehermann; J G McHutchison; C Pasquinelli; S Southwood; A Sette; F V Chisari
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.

Authors:  R Wyld; J R Robertson; R P Brettle; J Mellor; L Prescott; P Simmonds
Journal:  J Infect       Date:  1997-09       Impact factor: 6.072

7.  Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.

Authors:  Juan I Arenas; Juan F Gallegos-Orozco; Tomasz Laskus; Jeff Wilkinson; Amer Khatib; Carlos Fasola; Debra Adair; Marek Radkowski; Karen V Kibler; Marek Nowicki; David Douglas; James Williams; George Netto; David Mulligan; Goran Klintmalm; Jorge Rakela; Hugo E Vargas
Journal:  J Infect Dis       Date:  2004-05-10       Impact factor: 5.226

8.  Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Authors:  C Logvinoff; M E Major; D Oldach; S Heyward; A Talal; P Balfe; S M Feinstone; H Alter; C M Rice; J A McKeating
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

9.  Perinatal transmission and viral evolution of hepatitis C virus quasispecies in infants coinfected with HIV.

Authors:  Henry Pollack; Zhiying Hou; Austin L Hughes; William Borkowsky
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-01       Impact factor: 3.731

10.  Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape.

Authors:  Dirk Meyer-Olson; Naglaa H Shoukry; Kristen W Brady; Helen Kim; Douglas P Olson; Kelly Hartman; Ayumi K Shintani; Christopher M Walker; Spyros A Kalams
Journal:  J Exp Med       Date:  2004-08-02       Impact factor: 14.307

View more
  21 in total

1.  Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.

Authors:  G V Matthews; S T Pham; M Hellard; J Grebely; L Zhang; A Oon; P Marks; I van Beek; W Rawlinson; J M Kaldor; A Lloyd; G J Dore; P A White
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

2.  Mixed genotype transmission bodies and virions contribute to the maintenance of diversity in an insect virus.

Authors:  Gabriel Clavijo; Trevor Williams; Delia Muñoz; Primitivo Caballero; Miguel López-Ferber
Journal:  Proc Biol Sci       Date:  2009-11-25       Impact factor: 5.349

3.  Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection.

Authors:  Shazia Rafique; Muhammad Idrees; Amjad Ali; Muhammad Iqbal
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

Review 4.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

5.  Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

Authors:  Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

6.  Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes.

Authors:  Mengping Liu; Maria Tuttle; Min Gao; Julie A Lemm
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

7.  ANALYSIS OF HEPATITIS C VIRUS INFECTION MODELS WITH HEPATOCYTE HOMEOSTASIS.

Authors:  Timothy C Reluga; Harel Dahari; Alan S Perelson
Journal:  SIAM J Appl Math       Date:  2009-01-14       Impact factor: 2.080

8.  Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples.

Authors:  Andrew S Bae; Karin S Ku; Michael D Miller; Hongmei Mo; Evguenia S Svarovskaia
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

9.  Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.

Authors:  Sophie Le Pogam; Hyunsoon Kang; Seth F Harris; Vincent Leveque; Anthony M Giannetti; Samir Ali; Wen-Rong Jiang; Sonal Rajyaguru; Gisele Tavares; Connie Oshiro; Than Hendricks; Klaus Klumpp; Julian Symons; Michelle F Browner; Nick Cammack; Isabel Nájera
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

10.  Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.

Authors:  Hui Li; Mark B Stoddard; Shuyi Wang; Lily M Blair; Elena E Giorgi; Erica H Parrish; Gerald H Learn; Peter Hraber; Paul A Goepfert; Michael S Saag; Thomas N Denny; Barton F Haynes; Beatrice H Hahn; Ruy M Ribeiro; Alan S Perelson; Bette T Korber; Tanmoy Bhattacharya; George M Shaw
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.